Amarantus Announces Two New Independent Peer-Reviewed Publications for MANF
August 27, 2013 11:14 ET
|
Amarantus BioScience Holdings, Inc.
SUNNYVALE, Calif., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and...
Amarantus Strengthens Balance Sheet With Preferred Stock Transaction
August 19, 2013 16:05 ET
|
Amarantus BioScience Holdings, Inc.
SUNNYVALE, Calif., Aug. 19, 2013 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...
Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa
August 12, 2013 09:21 ET
|
Amarantus BioScience Holdings, Inc.
SUNNYVALE, Calif., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...
Amarantus Issues Mid-Year President's Letter to Shareholders
August 06, 2013 09:06 ET
|
Amarantus BioScience Holdings, Inc.
SUNNYVALE, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...